Macugen (pegaptanib sodium), a novel ocular therapeutic that targets vascular endothelial growth factor (VEGF). (Record no. 16635671)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01126 a2200277 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515044211.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200701s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0020-8167 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1097/01.iio.0000212130.91136.31 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Katz, Barrett |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20070109 |
245 00 - TITLE STATEMENT | |
Title | Macugen (pegaptanib sodium), a novel ocular therapeutic that targets vascular endothelial growth factor (VEGF). |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | International ophthalmology clinics |
Date of publication, distribution, etc. | 2006 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 141-54 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aptamers, Nucleotide |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Macular Degeneration |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Retinal Neovascularization |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vascular Endothelial Growth Factor A |
General subdivision | antagonists & inhibitors |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Goldbaum, Mauro |
773 0# - HOST ITEM ENTRY | |
Title | International ophthalmology clinics |
Related parts | vol. 46 |
-- | no. 4 |
-- | p. 141-54 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1097/01.iio.0000212130.91136.31">https://doi.org/10.1097/01.iio.0000212130.91136.31</a> |
Public note | Available from publisher's website |
No items available.